Company Description
First Citizens BancShares (NASDAQ: FCNCN) is a publicly traded company.
FCNCN stock has gained 1.8% over the past year. Shares last traded at $25.39.
On a trailing twelve-month basis, First Citizens BancShares reported revenue of $9.5B with net income of $2.2B and diluted earnings per share of $165.24. The company operates at a net profit margin of 23.1%.
This page provides a comprehensive overview of FCNCN stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
First Citizens BancShares (FCNCN) stock last traded at $25.39, up 0.04% from the previous close. Over the past 12 months, the stock has gained 1.8%.
FCNCN Rankings
Latest News
SEC Filings
First Citizens BancShares has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on June 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all FCNCN SEC filings →
Financial Highlights
First Citizens BancShares generated $9.5B in revenue over the trailing twelve months, and net income was $2.2B, reflecting a 23.1% net profit margin. Diluted earnings per share stood at $165.24. The company generated $2.9B in operating cash flow.
Upcoming Events
Short Interest History
Short interest in First Citizens BancShares (FCNCN) currently stands at 76.3 thousand shares, down 68.6% from the previous reporting period, representing 0.5% of the float. Over the past 12 months, short interest has decreased by 64.0%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for First Citizens BancShares (FCNCN) currently stands at 2.2 days, down 75.4% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 119% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 10.7 days.